Overview

Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that the addition of Mycograb to docetaxel will improve outcome in advanced carcinoma of the breast.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
NeuTec Pharma
Treatments:
Docetaxel
Efungumab